Investment Thesis
National Healthcare Corp demonstrates solid financial health with zero long-term debt and strong free cash flow generation (13.9% FCF margin), but fundamental profitability is deteriorating with net income declining 2.1% YoY despite 3.3% revenue growth, suggesting margin compression. Alarmingly low returns on capital (ROE 3.3%, ROA 2.4%) indicate the company is not efficiently deploying its $1.5B asset base, warranting a cautious stance until profitability trends improve.
Strengths
- Zero long-term debt provides exceptional financial flexibility and balance sheet resilience
- Strong free cash flow generation of $52.9M with 13.9% FCF margin relative to revenue
- Excellent liquidity position with current ratio of 1.86x and quick ratio of 1.82x
- Low capital intensity with CapEx at only 2.5% of revenue, enabling higher cash returns
Risks
- Net income declining 2.1% YoY while revenue grows 3.3% indicates operational margin compression and deteriorating profitability
- Critically low returns on capital with ROE of 3.3% and ROA of 2.4% suggest inefficient asset deployment and value destruction
- Anemic 3.3% revenue growth reflects limited market expansion in mature skilled nursing care sector facing demographic and regulatory headwinds
- EPS growth of 17.5% masking net income decline signals share buybacks compensating for weak underlying earnings fundamentals
- Skilled nursing care sector faces persistent labor cost inflation, regulatory pressures, and Medicare reimbursement uncertainty
Key Metrics to Watch
- Operating margin trend and sustainability amid labor cost pressures
- Net income growth rate relative to revenue growth to assess margin stability
- Return on equity and return on assets improvement trajectory
- Free cash flow conversion rate and ability to sustain 13%+ FCF margins
- Facility occupancy rates and average daily patient census movements
Financial Metrics
Revenue
381.8M
Net Income
35.9M
EPS (Diluted)
$2.27
Free Cash Flow
52.9M
Total Assets
1.5B
Cash
85.5M
Profitability Ratios
Gross Margin
N/A
Operating Margin
8.4%
Net Margin
9.4%
ROE
3.3%
ROA
2.4%
FCF Margin
13.9%
Balance Sheet & Liquidity
Current Ratio
1.86x
Quick Ratio
1.82x
Debt/Equity
0.00x
Debt/Assets
28.0%
Interest Coverage
7.80x
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-10T07:37:05.513197 |
Data as of: 2026-03-31 |
Powered by Claude AI